Factor v Leiden mutation in Arabs in Kuwait by real-time PCR: Different values for different Arabs

Journal of Human Genetics

Volumn 55, Issue 4, 2010, Pages 232-235

  Dashti, Ali A ^a   Jadaon, Mehrez M ^a   Lewis, Hend L ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Arabs; Factor V Leiden mutation; Kuwait; Real time PCR

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA EXTRACTION; EGYPT; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JORDAN; KUWAIT; MALE; NORMAL HUMAN; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SYRIAN ARAB REPUBLIC;

ADOLESCENT; ADULT; AGED; ARABS; FACTOR V; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KUWAIT; MALE; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77951700966     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.11     Document Type: Article

References (40)

1. Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H. D. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67 (1994).
2. Dahlbäck, B., Carlsson, M. & Svensson, P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl Acad. Sci. USA 90, 1004-1008 (1993).
3. Dahlbäck, B. Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays. Pros and Cons. Thromb. Haemost. 73, 739-742 (1995).
4. Ridker, P. M., Miletich, J. P., Hennekens, C. H. & Buring, J. E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thrmoboembolism screening. JAMA 277, 1305-1307 (1997).
5. Dahlbäck, B. Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis. Thromb. Haemost. 78, 483-488 (1997). (Pubitemid 27289289)
6. Faioni, E. M., Razzari, C., Martinelli, I., Panzeri, D., Franchi, F. & Mannucci, P. M. Resistance to activated protein C in unselected patients with arterial and venous thrombosis. Am. J. Hematol. 55, 59-64 (1997).
7. Rees, D. C., Cox, M. & Clegg, J. B. World distribution of factor V Leiden. Lancet 346, 1133-1134 (1995).
8. Zivelin, A., Griffin, J. H., Xu, X., Samama, M., Conard, J., Brenner, B. et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89, 397-402 (1997).
9. Hoagland, L. E., Triplett, D. A., Peng, F. & Barna, L. APC-resistnace as measured by a Textarin time assay: comparison to the APTT-based method. Thromb. Res. 83, 363-373 (1996).
10. Zö ller, B., Svensson, P. J., He, X. & Dahlbäck, B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J. Clin. Invest. 94, 2521-2524 (1994).
11. Alderborn, A., Siegbahn, A. & Wadelius, C. Venous thrombosis: factor V G1691A genetypeing related to APC resistance measured by 2 methods. Eur. J. Haematol. 58, 229-232 (1997).
12. Bontempo, F. A., Hassett, A. C., Faruki, H., Steed, D. L., Webster, M. W. & Makaroun, M. S. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. J. Vasc. Surg. 25, 271-275 (1997).
13. Florell, S. R. & Rodgers, G. M. Inherited thrombotic disorders: an update. Am. J. Hematol. 54, 53-60 (1997).
14. Samama, M. M., Simon, D., Horellou, M. H., Trossaë rt, M., Elalamy, I. Conard, J. Diagnosis and clinical characteristics of inherited activated protein C resistance. Haemostasis 26, 315-330 (1996).
15. Dahlbäck, B., Hillarp, A., Rosen, S. & Zö ller, B. Resistance to activated protein C, the FV:Q506 allele, and the venous thrombosis. Ann. Hematol. 72, 166-176 (1996).
16. Koeleman, B. P. C., Reitsma, P. H. & Bertina, R. M. Familial thrombophilia: a complex genetic disorder. Semin. Hematol. 34, 256-264 (1997).
17. Cox, M. J., Rees, D. C., Martinson, J. J. & Clegg, J. B. Evidence of a single origin of factor V Leiden. Br. J. Haematol. 92, 1022-1025 (1996).
18. Simioni, P., Prandoni, P., Lensing, A. W., Scudeller, A., Sardella, C., Prims, M. H. et al. The risk of recurrent venous thromboembolism in patients with an Arg506-Gmutation in the gene for factor V (factor V Leiden). N. Engl. J. Med. 336, 399-403 (1997).
19. Leroyer, C., Mercier, B., Escoffre, M., Férec, C. & Mottier, D. Factor V Leiden prevalence in venous thromboembolism patients. Chest. 111, 1603-1606 (1997).
20. Bennett, J. A., Palmer, L. J., Musk, A. W. & Erber, W. N. Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians. Thromb. Haemost. 86, 1592-1593 (2001).
21. Arruda, V. R., Annichino-Bizzacchi, J. M., Costa, F. F. & Reitsma, P. H. Factor V Leiden (FVQ 506) is common in a Brazilian population. Am. J. Hematol. 49, 242-243 (1995).
22. Zama, T., Murata, M., Ono, F., Watanabe, K., Watanabe, R., Moriki, T. et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int. J. Hematol. 65, 71-78 (1996).
23. Pepe, G., Rickards, O., Vanegas, O. C., Brunelli, T., Gori, A. M., Giusti, B. et al. Prevalence of factor V Leiden mutation in non-European populations. Thromb. Haemost. 77, 329-331 (1997).
24. Ho, C. H., Chau, W. K., Hsu, H. C., Gau, J. P. & Chih, C. M. Prevalence of factor V Leiden in the Chinese population. Zhonghua. Yi. Xue. Za. Zhi. 62, 875-878 (1999).
25. De Maat, M. P. M., Kluft, C., Jespersen, J. & Gram, J. World distribution of factor V Leiden mutation. Lancet. 347, 58 (1996).
26. Jadaon, M. M., Dashti, A. A. & Lewis, H. L. High prevalence of activated protein C resistance and factor V Leiden mutation in Arab population and patients with venous thrombosis in Kuwait. Diag. Mol. Pathol. (in press) (2010).
27. Rosen, E., Renbaum, P., Heyd, J. & Levy-Lahad, E. High frequency of factor V Leiden in a population of Israeli Arabs. Thromb. Haemost. 82, 1768 (1999).
28. Almawi, W. Y., Tamim, H., Kreidy, R., Timson, G., Rahal, E., Nabulsi, M. et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J. Thromb. Thrombolysis. 19, 189-196 (2005).
29. Dzimiri, N. & Meyer, B. World distribution of factor V Leiden. Lancet. 347, 481-482 (1996).
30. Irani-Hakime, N., Tamim, H., Elias, G., Finan, R. R., Daccache, J. L. & Almawi, W. Y. High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clin. Chem. 46, 134-136 (2000).
31. Taher, A., Khalil, I., Shamseddine, A., El-Ahdab, F. & Bazarbachi, A. High prevalence of factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb. Haemost. 86, 723-724 (2001).
32. Eid, S. S. & Shubeilat, T. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients. Blood Coagul. Fibrinolysis. 16, 417-421 (2005).
33. El-Karaksy, H., El-Koofy, N., El-Hawary, M., Mostafa, A., Aziz, M., El-Shabrawi, M. et al. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann. Hematol. 83, 712-715 (2004).
34. Pathare, A., Al Kindi, S., Al Haddabi, H., Dennison, D., Bayoumi, R. & Muralitharan, S. Hereditary thrombophilia in ethnic Omani patients. Am. J. Hematol. 81, 101-106 (2006).
35. Settin, A., Dowaidar, M., El-Baz, R., Abd-Al-Samad, A., El-Sayed, I. & Nasr, M. Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction. Hematology 13, 170-174 (2008).
36. Tamim, H., Finan, R. R. & Almawi, W. Y. Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb. Haemost. 88, 691-692 (2002).
37. Finan,R.R., Tamim, H., Ameen,G., Sharida, H. E.,Rashid, M. & Almawi, W Y Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am. J. Hematol. 71, 300-305 (2002).
38. Eid, S. S. & Rihani, G. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin. Lab. Sci. 17, 200-202 (2004).
39. Awidi, A., Shannak, M., Bseiso, A., Kailani, M. A. M., Kailani, M. A., Omar, N. et al. High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb. Haemost. 41, 582-584 (1999).
40. Almawi, W. Y., Keleshian, S. H., Borgi, L., Fawaz, N. A., Abboud, N., Mtiraoui, N. et al. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J. Thromb. Thrombolysis 20, 163-168 (2005).